EMA — authorised 11 February 2021
- Marketing authorisation holder: Eli Lilly Nederland B.V.
- Status: approved
🇪🇺 Retevmo in European Union
EMA authorised Retevmo on 11 February 2021
Marketing authorisation
Retevmo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Retevmo approved in European Union?
Yes. EMA authorised it on 11 February 2021.
Who is the marketing authorisation holder for Retevmo in European Union?
Eli Lilly Nederland B.V. holds the EU marketing authorisation.